| 产品详情 |
| Edit |   |
|---|
| Product Name | Elacridar hydrochloride |
|---|
| Description | P-glycoprotein (P-gp/ABCG1) inhibitor. Blocks P-gp-mediated multidrug resistance (MDR) of the cytotoxic drugs doxorubicin (Cat. No. 2252) and vincristine (Cat. No. 1257) in CHRC5 cells. Also inhibits breast cancer resistance protein (BCRP/ABCG2). Orally active. Purity 98%. MW (observed): 600.1 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N-[4-[2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-4-acridinecarboxamide hydrochloride. GF 120918 |
|---|
| Gene, Accession, CAS # | CAS: 143851-98-3 |
|---|
| Catalog # | 4646/10 |
|---|
| Price | |
|---|
| Order / More Info | Elacridar hydrochloride from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 24395888, 25574474, 26225433 |
|---|
| 产品资料 |
|
|